PREDICTION OF SEVERE ADAMTS13 DEFICIENCY IN PATIENTS WITH THROMBOTIC MICROANGIOPATHIES

被引：0
|
作者：
Nieto, J. M. [1 ]
De La Fuente-Gonzalo, F. [1 ]
Villegas, A. [1 ]
Gonzalez, F. A. [1 ]
Martin, M. P. [1 ]
Trujillo, C. [1 ]
Garcia-Paredes, L. [1 ]
Saez, M. [1 ]
Martinez, R. [1 ]
Ropero, P. [1 ]
机构：
[1] Hosp Clin San Carlos, Hematol, Madrid, Spain
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P405
引用
收藏
页码：142 / 143
页数：2
相关论文
共 50 条
  • [1] PREDICTION OF SEVERE ADAMTS13 DEFICIENCY IN PATIENTS WITH THROMBOTIC MICROANGIOPATHIES
    Martinez Nieto, Jorge
    De La Fuente-Gonzalo, Felix
    Gonzalez Fernandez, Fernando Ataulfo
    Ropero, Paloma
    Villegas, Ana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [2] ADAMTS13 in thrombotic microangiopathies
    Remuzzi, G
    Galbusera, M
    Mannucci, PM
    BLOOD, 2002, 100 (10) : 3842 - 3842
  • [3] Development and validation of a multivariable prediction rule for detecting a severe acquired ADAMTS13 activity deficiency in patients with thrombotic microangiopathies
    Nieto, Jorge M.
    De la Fuente-Gonzalo, Felix
    Gonzalez, Fernando A.
    Villegas, Ana
    Martinez, Rafael
    Fuentes, Manuel E.
    Ropero, Paloma
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (02) : 294 - 302
  • [4] The Use of ADAMTS13 Assays in Thrombotic Microangiopathies
    Cataland, Spero
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (11) : 687 - 689
  • [5] Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies
    Farkas, Peter
    Csuka, Dorottya
    Mikes, Balint
    Sinkovits, Gyorgy
    Reti, Marienn
    Nemeth, Endre
    Racz, Kristof
    Madach, Krisztina
    Gergely, Mihaly
    Demeter, Judit
    Prohaszka, Zoltan
    IMMUNOBIOLOGY, 2017, 222 (02) : 119 - 127
  • [6] Factor V Leiden is not a risk factor for thrombotic microangiopathies without severe ADAMTS13 deficiency.
    Hovinga, JAK
    Krieg, S
    Studt, JD
    Sulzer, I
    Lammle, B
    BLOOD, 2004, 104 (11) : 242A - 243A
  • [7] Discrepancies between ADAMTS13 activity assays in patients with thrombotic microangiopathies
    Mackie, Ian
    Langley, Katy
    Chitolie, Andrew
    Liesner, Ri
    Scully, Marie
    Machin, Samuel
    Peyvandi, Flora
    THROMBOSIS AND HAEMOSTASIS, 2013, 109 (03) : 488 - 496
  • [8] ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases
    Rieger, M
    Mannucci, PM
    Hovinga, JAK
    Herzog, A
    Gerstenbauer, G
    Konetschny, C
    Zimmermann, K
    Scharrer, I
    Peyvandi, F
    Galbusera, M
    Remuzzi, G
    Böhm, M
    Plaimauer, B
    Lämmle, B
    Scheiflinger, F
    BLOOD, 2005, 106 (04) : 1262 - 1267
  • [9] Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative
    Bendapudi, Pavan K.
    Li, Ang
    Hamdan, Ayad
    Uhl, Lynne
    Kaufman, Richard
    Stowell, Christopher
    Dzik, Walter
    Makar, Robert S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (05) : 836 - 844
  • [10] Relation between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA)
    Rieger, M
    Ferrari, S
    Hovinga, JAK
    Konetschny, C
    Herzog, A
    Koller, L
    Weber, A
    Remuzzi, G
    Dockal, M
    Plaimauer, B
    Scheiflinger, F
    THROMBOSIS AND HAEMOSTASIS, 2006, 95 (02) : 212 - 220
12345